Indium (¹¹¹In) biciromab

Indium (¹¹¹In) biciromab
Monoclonal antibody
Type	Fab' fragment
Source	Template:Infobox drug/mab source
Target	Fibrin II, beta chain
Legal status
Legal status	withdrawn;
Identifiers
CAS Number	138783-13-8
ATC code	none

Script error: No such module "TemplatePar".Expression error: Unexpected < operator.

Indium (¹¹¹In) biciromab (trade name FibriScint, developed by Centocor) was a drug targeting fibrin, a protein involved in the clotting of blood.^[1] It was the Fab' fragment of a mouse monoclonal antibody labelled with the radioisotope indium-111 for the diagnosis of thromboembolism,^[2] but was withdrawn during clinical trials.^[3]

References

Cite error: Invalid <references> tag; parameter "group" is allowed only.

Use <references />, or <references group="..." />

This monoclonal antibody-related article is a stub. You can help ssf by expanding it.

v t e Mouse monoclonal antibodies ("-o-")
"-govo-" (ovarian tumor)	Abagovomab, Igovomab, Oregovomab
"-limo-" (immune system)	Afelimomab, Elsilimomab, Faralimomab, Gavilimomab, Inolimomab, Maslimomab, Nerelimomab, Odulimomab, Telimomab aritox, Vepalimomab, Zolimomab aritox
"-tumo-" (miscellaneous tumor)	Altumomab pentetate, Anatumomab mafenatox, Arcitumomab, Bectumomab, Blinatumomab, CC49, Detumomab, Ibritumomab tiuxetan, Minretumomab, Mitumomab, Naptumomab estafenatox, Nofetumomab merpentan, Pemtumomab, Pintumomab, Satumomab pendetide, Taplitumomab paptox, Tenatumomab, Tositumomab, 3F8
"-leso-" (infectious lesions)	Besilesomab, Fanolesomab^§, Lemalesomab, Sulesomab
"-ciro-" (cardiovascular)	Biciromab^§, Imciromab^§
"-pro-" (prostate tumor)	Capromab pendetide
"-baco-" (bacterial)	Edobacomab
"-colo-" (colonic tumor)	Edrecolomab, Nacolomab tafenatox
^§Withdrawn